Announcements Trials
Browse Landscape

Status

Terminated 1Recruiting 1Completed 1

Sponsor Class

OTHER 3

Study Type

Observational 3Interventional 2

Sponsor

Cancer Type

CNS 10Lymphoid 3Breast 3Plasma cell 2Gastrointestinal 2Thoracic 1

Conditions

Triple Negative Breast Neoplasms 1Cancer Related Cognitive Difficulties 1Breast Neoplasms 1

Interventions

Surveys and Questionnaires 79Blood Specimen Collection 67palbociclib 40Trastuzumab 34Drug Therapy 30Letrozole 29Anastrozole 27Radiotherapy 26Immunohistochemistry 26Mastectomy, Segmental 22Amplified Fragment Length Polymorphism Analysis 22Fulvestrant 21Biopsy 21exemestane 20Tamoxifen 20Interviews as Topic 20Gene Expression Profiling 20Magnetic Resonance Spectroscopy 19ribociclib 18Specimen Handling 18Mastectomy 18Neoadjuvant Therapy 17Paclitaxel 16High-Energy Shock Waves 16Capecitabine 16trastuzumab deruxtecan 15Mammography 15Psychiatric Rehabilitation 14Polymerase Chain Reaction 13Observation 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Observational × Neuropsychological Tests × Breast × Clear all
NCT03137095 2026-04-24

Effects of Chemotherapy on Cognitive Function in Breast Cancer Patients & Non-Cancer Control Subjects With Optional Sub-Study Research Brain MRI

University of Rochester

Recruiting
150 enrolled
Breast

Cancer Related Cognitive Difficulties

NCT04835597 2024-08-26

Precision Performance Status Assessment in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy

M.D. Anderson Cancer Center

Terminated
27 enrolled
Breast

Triple Negative Breast Neoplasms

NCT00550134 2021-12-30

Cognitive Changes Associated With Breast Cancer Treatment

Memorial Sloan Kettering Cancer Center

Completed
53 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡